A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis
NCT05235269
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Amyloidosis
Interventions
DRUG:
124I-AT-01
Sponsor
Attralus, Inc.